| GTO ID | GTC3050 |
| Trial ID | NCT05397132 |
| Disease | Hematological Malignancy |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Recruitment status | Recruiting |
| Title | Mechanisms of Disease Relapse/Resistance in CAR T Therapy for Hematologic Malignancies |
| Year | 2022 |
| Country | United States |
| Company sponsor | Duke University |
| Other ID(s) | Pro00109903|1R21CA267275-01 |
| Cohort 1 | |||||||
|
|||||||